] [subheadPatients 18 to 39 years of age with early-onset cancer had a significantly high risk of harboring germline mutations, suggesting that this population should undergo germline genetic testing, irrespective of tumor type, according to results of a study that were presented during a press program ahead of the AACR Virtual Annual Meeting II.[/subhead]
The results showed that 21% of patients with early-onset cancer (n = 877) had a germline mutation versus 13% of patients with young-adult cancer (n = 324; P = .002). Read more . . . .